Startup entity

BARDA

organization

funding is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention DeepView System, the most common co-covered peer. They are less corroborated than the beat average, carrying 2 original sources each against 2.3 for the same window.

Last mentioned: Mar 24, 2026

Entity pulse

Recent coverage · BARDA

1 story
7 avg impact
100% positive
0% negative

Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.

  • 100% positive

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about BARDA

funding is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention DeepView System, the most common co-covered peer. They are less corroborated than the beat average, carrying 2 original sources each against 2.3 for the same window. Their average consequence score of 7 runs above the beat's 6.6 for that window. BARDA appears in 1 tracked Startup story from March 19, 2026.

Stories tracked
1
Sources per story
2

Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 48 Startup stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering BARDA. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. BARDA Award Announced

    Spectral AI receives $31.7 million to accelerate DeepView development.

  2. Clinical Validation Phase

    Planned acceleration of clinical trials and R&D activities funded by the award.

Stories mentioning BARDA 1

Funding Rounds Positive

Spectral AI Secures $31.7M BARDA Award to Scale AI Wound Diagnostics

Spectral AI has been awarded $31.7 million from the Biomedical Advanced Research and Development Authority (BARDA) to accelerate the development and clinical validation of its DeepView® System. This non-dilutive funding supports the integration of AI-driven predictive analytics into burn and wound care, aiming to improve triage and treatment outcomes in both clinical and emergency response settings.

2 sources

BARDA is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.